Viveve Medical Inc Quick Ratio (VIVE) starting from the third quarter 2022 to third quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Viveve Medical Inc   (NASDAQ: VIVE)

Viveve Medical Inc 's Quick Ratio

VIVE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2022, Quick Ratio fell to 0.55 below Viveve Medical Inc average.

Within Medical Equipment & Supplies industry 179 other companies have achieved higher Quick Ratio than Viveve Medical Inc in third quarter 2022. While Quick Ratio total ranking in the third quarter 2022 has deteriorated compared to the prior quarter from 2212 to 3141.

Explain Quick Ratio?
How much Cash & cash equivalents VIVE´s has?
What are VIVE´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VIVE Quick Ratio (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1		 (Dec 31 2021)
Q4		 (Sep 30 2021)
Q3
Y / Y Current Liabilities Change 181.55 % 238.93 % 140.01 % 7.54 % 14.93 %
Y / Y Cash & cash equivalent Change -73.94 % -62.86 % -50.63 % 193.76 % 146.36 %
Quick Ratio MRQ 0.55 0.94 1.37 4.23 5.89
VIVE's Total Ranking # 3141 # 2212 # 2082 # 650 # 810
Seq. Current Liabilities Change 8.24 % -2.45 % 126.41 % 17.77 % 30.3 %
Seq. Cash & cash equivalent Change -37.37 % -32.85 % -26.7 % -15.46 % -10.74 %



Quick Ratio third quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 180
Healthcare Sector # 1016
Overall Market # 3141


Quick Ratio Statistics
High Average Low
8.6 2.37 0.05
(Jun 30 2021)   (Mar 31 2015)




Financial Statements
Viveve Medical Inc 's Current Liabilities $ 11 Millions Visit VIVE's Balance sheet
Viveve Medical Inc 's Cash & cash equivalent $ 6 Millions Visit VIVE's Balance sheet
Source of VIVE's Sales Visit VIVE's Sales by Geography


Cumulative Viveve Medical Inc 's Quick Ratio

VIVE's Quick Ratio for the trailling 12 Months

VIVE Quick Ratio

 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months		 (Sep 30 2021)
12 Months
Y / Y Current Liabilities TTM Growth 133.07 % 93.71 % 30.97 % -7.07 % -19.04 %
Y / Y Cash & cash equivalent TTM Growth -41.53 % -6.12 % 54.29 % 187.58 % 107.3 %
Quick Ratio TTM 1.36 2.28 3.76 6.13 5.43
Total Ranking TTM # 4545 # 4137 # 4343 # 4177 # 638
Seq. Current Liabilities TTM Growth 24.38 % 32.68 % 38.35 % 2.08 % 3.38 %
Seq. Cash & cash equivalent TTM Growth -25.66 % -19.64 % -15.05 % 15.22 % 19.36 %

Quick ratio ranking by company, industry and sector >> Back to VIVE Financial Strength Comparisons >> Go to Compare VIVE Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2022 to $10.84 millions, cumulative Quick Ratio decreased to 1.36 below the Viveve Medical Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 244 other companies have achieved higher Quick Ratio than Viveve Medical Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2022 from 4137 to 4545.

Explain Quick Ratio?
How much Cash & cash equivalents VIVE´s has?
What are VIVE´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 245
Healthcare Sector # 1174
Within the Market # 4545


trailing twelve months Quick Ratio Statistics
High Average Low
6.13 2.68 0.76
(Dec 31 2021)   (Sep. 30, 2015)




Companies with similar Quick Ratio in the quarter ending Sep 30 2022, within Medical Equipment & Supplies Industry Quick RatioSep 30 2022 MRQ Cash & cash equivalentSep 30 2022 MRQ Current Liabilities
Innovage Holding Corp   1.43 $ 188.222  Millions$ 131.415  Millions
Agape Atp Corporation  1.43 $ 1.585  Millions$ 1.107  Millions
Universal Biosensors Inc   1.42 $ 17.337  Millions$ 12.222  Millions
Orasure Technologies Inc  1.42 $ 101.637  Millions$ 71.697  Millions
Pavmed Inc   1.39 $ 56.785  Millions$ 40.884  Millions
Paragon 28 inc   1.35 $ 56.325  Millions$ 41.607  Millions
Penumbra Inc  1.33 $ 184.427  Millions$ 138.332  Millions
Outset Medical Inc   1.29 $ 63.877  Millions$ 49.644  Millions
Biolase Inc   1.26 $ 9.960  Millions$ 7.905  Millions
Harpoon Therapeutics Inc   1.22 $ 66.098  Millions$ 54.061  Millions
Zynex inc   1.19 $ 23.532  Millions$ 19.770  Millions
Embecta Corp   1.18 $ 330.900  Millions$ 279.500  Millions
Genedx Holdings Corp   1.18 $ 191.360  Millions$ 162.331  Millions
Vivos Therapeutics Inc   1.13 $ 6.719  Millions$ 5.964  Millions
Sanara Medtech Inc   1.12 $ 10.285  Millions$ 9.206  Millions
Meihua International Medical Technologies Co Ltd  1.11 $ 26.737  Millions$ 24.174  Millions
Cerus Corporation  1.09 $ 103.827  Millions$ 95.019  Millions
Privia Health Group Inc   1.05 $ 316.896  Millions$ 301.531  Millions
Assure Holdings Corp   1.04 $ 3.798  Millions$ 3.646  Millions
Electromed Inc   1.01 $ 5.998  Millions$ 5.953  Millions
Marizyme Inc   1.00 $ 1.182  Millions$ 1.185  Millions
Inspiremd Inc   0.99 $ 3.934  Millions$ 3.961  Millions
Heartsciences Inc   0.99 $ 3.076  Millions$ 3.108  Millions
Delcath Systems Inc   0.98 $ 13.982  Millions$ 14.250  Millions
Dror Ortho-Design, Inc.  0.97 $ 0.098  Millions$ 0.101  Millions
Sientra Inc   0.96 $ 18.975  Millions$ 19.868  Millions
Sonoma Pharmaceuticals Inc   0.95 $ 3.351  Millions$ 3.527  Millions
Northview Acquisition Corp  0.93 $ 0.373  Millions$ 0.400  Millions
Haemonetics Corporation  0.92 $ 241.200  Millions$ 262.175  Millions
Strata Skin Sciences Inc  0.91 $ 7.454  Millions$ 8.202  Millions

Date modified: 2026-09-08T15:10:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.